Can a 40 mg/mL triamcinolone acetate suspension be diluted with bacteriostatic water?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dilution of Triamcinolone Acetonide 40 mg/mL with Bacteriostatic Water

Do not dilute triamcinolone acetonide 40 mg/mL suspension with bacteriostatic water for intralesional injection; use the standard 40 mg/mL concentration directly, or if dilution is necessary for thinner lesions, use preservative-free sterile water or saline instead. 1

Rationale for Standard Concentration

  • The 40 mg/mL concentration (TAC-40) is the established standard for intralesional treatment of keloids and hypertrophic scars and should be used without dilution for most clinical applications. 1

  • For smaller or thinner lesions where lower concentrations are clinically indicated (5–10 mg/mL), dilution may be performed, but the choice of diluent is critical to avoid complications. 1

Why Bacteriostatic Water Is Problematic

  • Bacteriostatic water contains benzyl alcohol as a preservative, which has documented toxic effects on tissues, particularly in ophthalmic applications where extensive research has focused on eliminating this preservative from triamcinolone preparations. 2, 3, 4

  • Multiple studies demonstrate that benzyl alcohol at concentrations of 9.9 mg/mL (found in commercial triamcinolone products) causes tissue damage, prompting development of preservative-free formulations. 5, 2, 3

  • While the concentration of benzyl alcohol in bacteriostatic water (0.9%) is lower than in some commercial triamcinolone products, introducing any preservative into an intralesional injection increases the risk of local tissue toxicity, particularly skin atrophy—already the most consistent adverse effect of triamcinolone injections. 1

Recommended Dilution Approach (When Necessary)

  • If dilution is clinically required for thinner lesions, use preservative-free sterile distilled water or 0.9% sodium chloride for injection (without preservatives). 6, 5, 3

  • Sterile distilled water has been successfully used to create preservative-free triamcinolone suspensions with proven stability, sterility, and safety profiles for injection. 5, 3

  • The direct suspending method using sterile water provides a stable, preservative-free preparation that fulfills compendial requirements and maintains a reasonable shelf-life. 3

Practical Injection Guidelines

  • Use the standard 40 mg/mL concentration for most keloid treatments, injecting 0.05–0.1 mL per site (treating approximately 0.5 cm diameter area). 1

  • Place the needle just beneath the dermis, within the upper subcutis, to maximize local effect and limit systemic absorption. 1

  • For lesions requiring lower concentrations (5–10 mg/mL), prepare dilutions fresh using preservative-free sterile water, maintaining sterile technique throughout. 1, 5

Common Pitfalls to Avoid

  • Avoid using bacteriostatic water or any preservative-containing diluent, as this adds unnecessary risk of tissue toxicity without clinical benefit. 2, 3

  • Do not assume that lower preservative concentrations are safe—the goal should be complete elimination of preservatives from intralesional preparations. 5, 3

  • Ensure proper sterile technique when preparing any dilutions, as contamination risk increases with manipulation of the original formulation. 5, 3

References

Guideline

Intralesional Triamcinolone Acetonide for Keloid Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Preservative-free triamcinolone acetonide suspension developed for intravitreal injection.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008

Research

[Triamcinolone acetonide without solvents].

Archivos de la Sociedad Espanola de Oftalmologia, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.